Back to BLACKROCK ADVISORS LLC BLACKROCK ADVISORS LLC

CYTKCYTK

Showing 0 of 10 quarters

Position history for BLACKROCK ADVISORS LLCBLACKROCK ADVISORS LLC's holdings in CYTOKINETICS INC

As of its last 13F, for Q4 2016, BlackRock Advisors held 123,763 shares of CYTK (Cytokinetics), worth $1.5M. It increased the position by 948 shares (+0.8%) from Q3 2016. BlackRock Advisors held CYTK from Q3 2014 to Q4 2016, across 10 quarterly 13F filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used